- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Consultant Clinical Oncologist � Prostate Cancer Specialist
Dr. Milan Anjanappa is a Consultant Clinical Oncologist specialising in the non-surgical treatment of prostate and complex urological cancers. He has over a decade of experience, having qualified as an Oncologist in 2015.
His aim is simple - to provide the highest standard of personalised cancer care while helping patients make confident, informed decisions about their treatment.
He has a busy NHS practice based at Mount Vernon Cancer Centre in London, one of the UK's leading specialist cancer centres. He sees many complex cases and delivers advanced, personalised treatment using the latest radiotherapy and systemic therapies.
His private practice focuses on comprehensive
care for men with prostate cancer, offering expert guidance and modern
treatment options, including advanced radiotherapy techniques, hormone therapy,
chemotherapy, immunotherapy, and targeted therapies, particularly for complex
or challenging cases.
Dr. Anjanappa combines technical expertise
with a strong commitment to patient-centred care, ensuring each treatment plan
is tailored to the individual's needs and priorities.
Advanced Prostate and Cancer Treatments
Dr Anjanappa specialises in the management of prostate cancer at all stages, from
newly diagnosed early disease through to advanced and recurrent cancer.
He has extensive expertise in state-of-the-art, non-surgical cancer treatments such as
radiotherapy and systemic treatments, including:
� Precision radiotherapy techniques (image-guided, stereotactic, MR-guided)
� Prostate brachytherapy (high-dose-rate and low-dose-rate seeds)
� Systemic therapies such as hormone therapy, chemotherapy,
immunotherapy, and targeted treatments
� Innovative therapies including Lu-PSMA radioligand therapy for advanced prostate cancer
Dr. Anjanappa's approach allows treatments to be used alone or in combination, tailored to the patient's individual needs.
He is particularly experienced in treating patients who:
Are exploring alternatives to surgery
� Have complex or recurrent prostate cancer
Require advanced radiotherapy techniques
� Are seeking highly individualised treatment planning or a second opinion
His expertise in advanced radiotherapy and targeted therapies ensures cancer is treated as effectively as possible while minimising side effects and preserving quality of life.
Dr Anjanappa is actively involved in clinical research aimed at improving outcomes
for patients with prostate cancer.
He has participated in numerous clinical trials and research studies as both Principal
Investigator and Sub-Investigator.
His research work includes involvement in major prostate cancer trials such as:
STAR-TRAP
POINTER-PC
STAMPEDE 2
These trials don't just test new treatments; they inform the future standard of care.
The knowledge gained means more patients can receive safer, more effective, and personalised treatment, even if their cancer has returned or spread.
He has published in peer-reviewed medical journals and presented at national and international conferences.
Dr Anjanappa is recognised by colleagues and patients alike for his thoughtful,
thorough and compassionate care.
Patients value his willingness to spend time explaining complex medical information in a
clear and understandable way.
His combination of specialist expertise, advanced treatments and patient-centred
care makes him a trusted choice for men seeking expert treatment for prostate
cancer.
Areas of interest
Prostate cancer; seed brachytherapy; Lutetium-177 PSMA therapy; HDR brachytherapy; SABR/SBRT; 5-day prostate radiotherapy; MR Linac; Kidney SABR/SBRT; radiotherapy; IMRT/IGRT; chemotherapy; hormone therapy; immunotherapy; bladder cancer; Oligo-metastasis SABR/SBRT
Medical secretaries
- Amy Bignell
- Mount Vernon Cancer Centre Rickmansworth Road Northwood Middlesex HA6 3NN
- 020 3826 2182
- abignell@macancerclinic.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Mount Vernon Cancer Centre (5-50)
-
X6910
Clinical supervision of the planning of a course of simple radiotherapy - (1-5)
-
X6581
Clinical supervision of the delivery of a single fraction of radiotherapy - (1-5)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
-
H4685
Insertion of biodegradable perirectal spacer under image guidance - (1-5)
- Show All (8 )...